Other ECM components such as small-size hyaluronan synthase-3 (HAS-3) have been linked to malignant processes in a variety of carcinomas, while isoform HAS-2 downregulation has shown cisplatin resensitization and tumor growth arrest in OSCCs. The gene discussed is HAS3; the disease is carcinoma.